Genome International Biomedical Co. Ltd filed its Annual on Mar 27, 2015 for the period ending Dec 31, 2014. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.95 TWD | -2.18% | +0.94% | -21.66% |
1st Jan change | Capi. | |
---|---|---|
-21.66% | 36.78M | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+5.13% | 8.59B | |
+8.25% | 8.38B | |
-19.42% | 8.09B | |
+5.56% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
-1.65% | 3.93B |
- Stock Market
- Equities
- 6130 Stock
- News Shangya Technology Co., Ltd.
- Genome International Biomedical Co. Ltd Auditor Raises 'Going Concern' Doubt